Skip to main content

Table 3 The comparison of adverse events

From: Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients

 

Mirogabalin group

(N = 13)

Pregabalin group

(N = 21)

P value

Adverse events, n (%)

2 (15.4)

7 (33.3)

0.43

Dizziness

1 (7.7)

2 (9.5)

 

Edema

1 (7.7)

2 (9.5)

 

Sleepiness

0

3 (14.3)

 
  1. Values are shown as n (%)
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us